Our ZooMAb® recombinant antibodies platform represents an entirely new generation of recombinant monoclonal antibodies that offer the superior specificity and affinity of a monoclonal and polyclonal combined with the flexibility of a recombinant for a wider selection of targets, formats, and species. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Each antibody is validated to reliably perform across multiple applications, including its most commonly used application. For more information on the revolutionary benefits of our ZooMAb® recombinant antibody technology, please visit our ZooMAb® technical resource page.
Our first group of ZooMAb® antibodies are rabbit-derived, which can produce a large variety of desirable antibodies against “difficult” immunogens in mice, including small molecules (compounds of <600 kDa), peptides, and antibodies specific for post-translational modification sites (PTM). By recognizing a higher diversity of epitopes per antigen at the picomolar level with high specificity, rabbit antibodies tend to provide excellent results in both standard assays and staining applications. For additional information for frequently asked questions, please visit our ZooMAb® antibodies FAQ resource page.
Every ZooMAb® antibody is provided as a lyophilized product, individually packaged to provide long-term stability, faster shipping, and minimize non-value-added costs that typically incur through cold chain handling of liquids, including the thermal insulated packaging used in transportation. Therefore, every ZooMAb® antibody is exceptionally stable to allow for ambient shipping and storage if needed.
Every ZooMAb® antibody is provided free of biocides like sodium azide or preservatives of animal origin, such as bovine serum albumin (BSA), and finished in a simple phosphate buffered saline (PBS) with trehalose. With ZooMAb® antibodies, complications arising from potentially hazardous materials or local safety restrictions are minimized and allow its use in both in vivo and in vitro applications.
Every ZooMAb® antibody is produced without the harm or sacrifice of animals. The proprietary recombinant expression system eliminates the need for arduous cell fusion and hybridoma construction, while providing greater specificity, affinity and reproducibility than monoclonal counterparts.
Every ZooMAb® antibody is pre-aliquoted at 25 µL lyophilized equivalents to maximize product shelf life. Hence, you only purchase what you need and resuspend what you will use for your research.
ZooMAb® antibodies are recombinantly produced, purified and pre-aliquoted for you. Every antibody is tested in our own laboratory to work in at least 3 applications and ensured to perform the way you would expect it to in western blotting, immunofluorescence, and other common applications.
Use the convenient QR code printed on each ZooMAb® product label to find up to date information on all the newest additions to our ZooMAb® antibody portfolio and share your experience with these products. Our ZooMAb® antibodies are designed and tested with your needs in mind and are backed by our Antibody Guarantee. We stand by the quality of our product with our Antibody Guarantee, if our antibody does not perform in applications described in our documentation, including product listings on our websites, catalogues or data sheets, we will issue a full credit or replacement antibody product. Click here to learn more.
Unless otherwise stated in the Product(s) specifications, any Antibody product is sold for internal research use only and may not be used for any other purpose, which includes but is not limited to, any commercial, diagnostic, or therapeutic use. Our validation processes pertain only to research uses and do not confirm or assure that our antibodies can be used for any unauthorized uses as set forth herein.